Veristat, a global clinical research organization (CRO) and consultancy, will [...]
OptymEdge has appointed Amy Del Medico as senior director of [...]
SeaBeLife, a biotechnology company developing novel drug candidates to block [...]
SpotitEarly, a US-based early cancer detection startup, has announced a [...]
Kairos Pharma has announced encouraging interim efficacy results from its [...]
AstraZeneca has reported positive interim results from the Phase 3 [...]
Amber Implants has received FDA 510(k) clearance for its VCFix [...]
Cook MyoSite and Veristat progress Phase 3 trial of cell therapy for women with chronic incontinence
Cook MyoSite and Veristat have reached a key enrolment milestone [...]
Barcelona-based biotech advances Huntington’s programme as EMA backs orphan designation, [...]
Galimedix Therapeutics has completed a phase 1 study of its [...]